Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Asep Medical Holdings Inc C.ASEP

Alternate Symbol(s):  SEPSF

ASEP Medical Holdings Inc. is a Canada-based company, which is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. The Company’s consolidates three development-stage companies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. It provides medical devices with an anti-microbial, antifouling coating through its SafeCoat Medical Inc. The Company provides diagnostic kits for predicting the onset of severe Sepsis and organ failure through its Sepset Biosciences Inc. The Company also offers peptide technology through its ABT Innovations Inc. and covers a range of therapeutic applications, including bacterial biofilm infections, anti-inflammatories, anti-infective immune-modulators and vaccine adjuvants. SafeCoat Medical Inc.'s technology incorporates self-assembling biocompatible polymers combined with conjugated antimicrobial peptides.


CSE:ASEP - Post by User

Post by StockHawk1on Jan 11, 2022 4:39pm
99 Views
Post# 34305555

$ASEP DD

$ASEP DD

If you're interested in the biotech sector Asep Medical Holdings Inc ( $ASEP.C ) is a company to look into. $ASEP is directly addressing sepsis through sepsis detection and peptide technology. 


Its sepsis detection technology detects sepsis 23 hours earlier than industry-standard tests and is currently in global clinical trial phases. 


$ASEP's peptide tech breaks down biofilms that grow on many forms of bacteria (including that which causes sepsis). This allows for antibiotics to directly attack the bacteria. 


RN $ASEP.C is trading at just $0.60, which IMO is still a great price considering that the company is planning to apply for regulatory approval for their detection tech in the coming months.


<< Previous
Bullboard Posts
Next >>